We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Feedback Plc | LSE:FDBK | London | Ordinary Share | GB00BJN59X09 | ORD 50P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 60.50 | 60.00 | 61.00 | 60.50 | 60.50 | 60.50 | 14,770 | 07:44:37 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Electronic Computers | 1.03M | -2.92M | -0.2188 | -2.77 | 8.07M |
Date | Subject | Author | Discuss |
---|---|---|---|
22/8/2019 11:36 | Whilst waiting for the Test to start some reading:- Providers and commissioners of NHS services There are in England: 207 clinical commissioning groups10 135 acute non-specialist trusts (including 84 foundation trusts) 17 acute specialist trusts (including 16 foundation trusts) 54 mental health trusts (including 42 foundation trusts) 35 community providers (11 NHS trusts, 6 foundation trusts, 17 social enterprises and 1 limited company) 10 ambulance trusts (including 5 foundation trusts)11 7,454 GP practices12 853 for-profit and not-for-profit independent sector organisations, providing care to NHS patients from 7,331 locations13 | ged5 | |
22/8/2019 10:55 | Thanks Davy and Megan for your comments which give some insight to the placing procedure. There is a section on the Feedback websight - Investor Relations. In that section is Reports and Presentations. It would be an excellent place to put any presentation so that ALL can see it. Ironically the last Annual report is in that section, where it states:- "Feedback encourages two-way communication with its investors and responds quickly to queries received. The Company has an email address(IR@fbk.com) where shareholders can communicate with the Board. The Directors are available to shareholders at any time to discuss strategy and governance matters. The Chairman communicates regularly with major shareholders and ensures that their views and concerns are fully communicated back to the Board and management team. In addition,all Company announcements are published on the Company’s website, together with Financial results. All shareholders have the opportunity to ask questions and express their views at the Company’s Annual General Meeting, at which Directors are available to take questions. Should voting decisions not be in line with Board’s expectations then the Board will liaise with shareholders in order to address any issues." Should be a good meeting then, for those that go! | ged5 | |
22/8/2019 10:45 | thanks meganxmas, all as i'd hoped, and I share your reasons for interest here. Having watched this for years it was TO description on proactive of leveraging Cadran with something (that was later announced to be Bleepa)that convinced me to invest and build quickly | davydoo | |
22/8/2019 10:20 | Just to add to that the way it works is that you have to agree to go inside even before you know the name of the company involved. From that point on and until the relevant corporate activity is announced cannot trade (long or short or otherwise) in your name or via persons associated with you. If you do are commiting a criminal offence (let's face it we know/suspect that some do including unscrupulous brokers ... I am NOT saying that happened here). You also undertake not to share information as obviously so doing allows others to trade with inside knowledge.In Feedback's case there was nothing earth shattering in what I was told ... this was a raising of funds to deliver Bleepa, the product announced shortly before. Projections are difficult as depends on take up and of course ease of integration hence my questions. However do the sums ... number of hospitals, health boards, doctors, nurses, etc. Could be very big indeed. If executed well and quickly. Competition is possible but the differentiator is the medical grade imaging via CADRAN. If this was just a chat/communication app would not be interested. It is much more. | meganxmas | |
22/8/2019 10:10 | Ged5 I tried to get in on the placing, and was asked to commit to becoming in effect an insider, and to not share information or trade my current holding on the basis of what ever information I would've been given. I don't know if that meant a presentation, they never followed up with me, I assume because the leak was rumbled and they had to rush for commitments and then got them. All my speculation. Maybe my holding wasn't big enough. Whilst I understand as an existing investor we'd want the same information as a prospective investor, on balance I think its ok to share inside information with potential investors since without their commitment discreet plans may never see the light of day. If the existing investor wants to know more, the onus is on them get on the placing list. | davydoo | |
22/8/2019 09:53 | Ged ,, Best not to go there ! | botak54 | |
22/8/2019 09:39 | Megan, were you invited to an institution investor presentation as a PI? When was the presentation? The next bit's not particularly for you unless of course you can answer. Thank you for your answers so far. So there is a presentation given to institutions. I wonder if it's in written form such as a Powerpoint. If it is why just give it to new investors and not to LTH? Surely any presentation should be made available to all? | ged5 | |
22/8/2019 09:29 | Absolutely GED but an email doesn't have to be shared megan chose to. Don't let us fall out now! 8-) | hazl | |
22/8/2019 09:15 | Thanks for your reply. So the thanks were for taking part in the placing. Perhaps I'm just peeved that he's no longer replying to my more pertinent questions. It's also my right to ask questions, hazl. | ged5 | |
22/8/2019 08:57 | Have inserted 1, 2 and 3 where were in the email.Just in case of interest question I asked Tom and answer given ... helped my understanding anyway. Thank you for your email. I hope the following explanation makes sense but if not then just let me know.Cadran is a Picture Archiving and Communication System (PACS), in essence a library and display tool for medical images that are stored in a format called DICOM. All imaging is handled in the DICOM format as standard, internationally. Cadran is the imaging tool that powers Bleepa and it can integrate with other PACS that are already present within a hospital, meaning that the hospital doesn't need to change out any of its existing IT infrastructure, we just bolt onto the existing system - as you say this greatly broadens the addressable market. Where a site doesn't have a PACS (i.e. India for example) Cadran can act as the sole PACS. Cadran acts as an imaging processor that allows the medical images in question to be viewed through a web app on any device.Many thanksTomThank you for your time yesterday, greatly appreciated.Can I just ask for confirmation regarding CADRAN and PACS ...1) My understanding is that CADRAN is an imaging storage, archiving and distribution platform (software ? or software + hardware ?) that allows medical images to be viewed via PCs etc.2) Bleepa is an extension (APP) that would allow these pictures to be securely shared and integrated with chat / discussion via mobile devices.3) The CADRAN system works with any imaging hardware that operates on the DICOM standardSo ... for hospitals / facilities to integrate Bleepa it doesn't matter what imaging devices are used (as long as DICOM compliant) but they would need to implement CADRAN (at what cost / impact versus existing system)OR4. Bleepa can be integrated with other image storage platforms therefore making the addressable market much bigger and more easily acessible | meganxmas | |
22/8/2019 08:54 | Hi the text was the full email apart from names and numbers. The 1, 2 and 3 have been transposed when pasting into advfn for some reason but it is basically the narrative above 3. The context of the email was that I had a 45 min discussion by phone before as I was unable to attend institution investor presentations as part of the proposed fundraise. I am in scotland and couldn't make it to london due to other commitments. Hope that helps and nothing underhand or hidden. | meganxmas | |
22/8/2019 08:52 | I guess that's megan's prerogative. I am pleased that it was posted at all but certainly if Megan has more to say it would be welcomed. | hazl | |
22/8/2019 08:46 | Interesting post yesterday evening, Megan. I see you got a similar answer to the question asked by Bob on 15th July. I am intrigued why the email was signed off "Many thanks". You've obviously had some dialogue. May I be so bold as to ask under what circumstance you had the dialogue. Of course your email must have been more substantial than what you've posted. If point 4 was:- "4. Bleepa can be integrated with other image storage platforms therefore making the addressable market much bigger and more easily acessible" (accessible) what were the other 3 points and were there any more points? Why if you had permission to post did you only post part of the email? | ged5 | |
22/8/2019 07:54 | Lots TO LOOK FORWARD TO. | hazl | |
21/8/2019 20:54 | And 200,000,000 overhang, lol. | ducatiman | |
21/8/2019 20:38 | Only a two weeks away! | hazl | |
21/8/2019 20:37 | If this takes off l can't imagine it staying this price for long. | hazl | |
21/8/2019 20:26 | Cheers hazl. India mentioned, interesting. | ducatiman | |
21/8/2019 19:28 | No problem ... I did ask his permission today before sending ... he said no problem as nothing price sensitive. | meganxmas | |
21/8/2019 19:21 | Thank you megan for passing that on. | hazl | |
21/8/2019 19:10 | Just in case of interest question I asked Tom and answer given ... helped my understanding anyway. Thank you for your email. I hope the following explanation makes sense but if not then just let me know.Cadran is a Picture Archiving and Communication System (PACS), in essence a library and display tool for medical images that are stored in a format called DICOM. All imaging is handled in the DICOM format as standard, internationally. Cadran is the imaging tool that powers Bleepa and it can integrate with other PACS that are already present within a hospital, meaning that the hospital doesn't need to change out any of its existing IT infrastructure, we just bolt onto the existing system - as you say this greatly broadens the addressable market. Where a site doesn't have a PACS (i.e. India for example) Cadran can act as the sole PACS. Cadran acts as an imaging processor that allows the medical images in question to be viewed through a web app on any device.Many thanksTomThank you for your time yesterday, greatly appreciated.Can I just ask for confirmation regarding CADRAN and PACS ...My understanding is that CADRAN is an imaging storage, archiving and distribution platform (software ? or software + hardware ?) that allows medical images to be viewed via PCs etc. Bleepa is an extension (APP) that would allow these pictures to be securely shared and integrated with chat / discussion via mobile devices.The CADRAN system works with any imaging hardware that operates on the DICOM standardSo ... for hospitals / facilities to integrate Bleepa it doesn't matter what imaging devices are used (as long as DICOM compliant) but they would need to implement CADRAN (at what cost / impact versus existing system)OR4. Bleepa can be integrated with other image storage platforms therefore making the addressable market much bigger and more easily acessible | meganxmas | |
21/8/2019 14:56 | It's funny but there are two posters that sound very similar on this thread....same turn of phrase similar views.....hmm. | hazl | |
21/8/2019 14:02 | Bleepa @BleepaMe 1m1 minute ago More so who is excited for @ExpoNHS in only 2 weeks time?? The #Bleepa team at @FBKmed certainly are! Make sure to come and visit us at Stand 29 to see the Future of NHS Communication | newtothisgame3 | |
21/8/2019 13:45 | hazl I could list if you so require , That,s the reason not to engage on repetitive negative , otherwise we will be discussing toxic subjects , The company game changer is more appealing | botak54 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions